$EXAS
EXACT SCIENCES CORP Stock $exas

$exas Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000112414022000061 Filed on August 02, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$523.1M	$521.6M	$486.6M
YoY Change	14.61%	19.97%	21.01%
Cost Of Revenue	$147.9M	$144.6M	$134.7M
YoY Change	27.82%	26.88%	22.47%
Gross Profit	$375.1M	$377.0M	$351.9M
YoY Change	17.44%	25.82%	29.59%
Gross Profit Margin	71.72%	72.28%	72.32%
Selling, General & Admin	$379.7M	$397.6M	$402.0M
YoY Change	-0.91%	9.69%	-11.44%
% of Gross Profit	101.21%	105.45%	114.23%
Research & Development	$90.81M	$106.1M	$102.2M
YoY Change	20.51%	-0.14%	-11.52%
% of Gross Profit	24.21%	28.14%	29.06%
Depreciation & Amortization	$25.00M	$25.50M	$22.99M
YoY Change	12.11%	18.6%	12.12%
% of Gross Profit	6.66%	6.76%	6.53%
Operating Expenses	$470.5M	$503.7M	$504.2M
YoY Change	-2.28%	6.86%	-11.86%
Operating Profit	-$138.1M	-$159.6M	-$177.0M
YoY Change	-14.79%	-7.04%	-41.11%
Interest Expense	-$13.82M	-$8.230M	-$5.965M
YoY Change	57.52%	572.94%	-122.45%
% of Operating Profit
Other Income/Expense, Net	-$13.82M	-$8.230M	-$5.965M
YoY Change	57.52%	572.94%	-122.45%
Pretax Income	-$151.9M	-$167.8M	-$183.0M
YoY Change	-11.08%	-2.93%	-33.22%
Income Tax	-$3.100M	-$1.800M	-$2.000M
% Of Pretax Income
Net Earnings	-$148.8M	-$166.1M	-$180.9M
YoY Change	-10.89%	-6.13%	480.6%
Net Earnings / Revenue	-28.44%	-31.83%	-37.19%
Basic Earnings Per Share	-$0.84	-$0.94	-$1.04
Diluted Earnings Per Share	-$0.84	-$0.94	-$1.04
COMMON SHARES
Basic Shares Outstanding	177.0M shares	176.4M shares	174.4M shares
Diluted Shares Outstanding	177.0M shares	176.4M shares	174.4M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$669.1M	$728.0M	$817.0M
YoY Change	-45.09%	-44.32%	-40.71%
Cash & Equivalents	$235.3M	$213.4M	$189.8M
Short-Term Investments	$433.8M	$514.6M	$627.2M
Other Short-Term Assets	$75.49M	$71.88M	$79.58M
YoY Change	44.1%	58.72%	52.54%
Inventory	$114.7M	$115.2M	$113.0M
Prepaid Expenses
Receivables	$189.2M	$186.5M	$205.6M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.049B	$1.102B	$1.215B
YoY Change	-35.1%	-34.0%	-31.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$857.3M	$855.6M	$622.6M
YoY Change	63.54%	70.48%	28.98%
Goodwill	$2.345B	$2.346B	$2.335B
YoY Change	4.58%	4.61%	6.93%
Intangibles	$1.978B	$2.047B	$2.070B
YoY Change	-3.29%	-2.03%	-0.2%
Long-Term Investments
YoY Change
Other Assets	$88.74M	$96.68M	$77.48M
YoY Change	49.79%	76.88%	36.07%
Total Long-Term Assets	$5.258B	$5.336B	$5.275B
YoY Change	4.35%	5.55%	6.38%
TOTAL ASSETS
Total Short-Term Assets	$1.049B	$1.102B	$1.215B
Total Long-Term Assets	$5.258B	$5.336B	$5.275B
Total Assets	$6.307B	$6.437B	$6.491B
YoY Change	-5.23%	-4.27%	-3.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$63.58M	$84.17M	$66.47M
YoY Change	52.42%	130.01%	91.54%
Accrued Expenses	$308.0M	$308.2M	$365.9M
YoY Change	1.08%	15.87%	70.87%
Deferred Revenue	$2.300M	$1.200M	$1.300M
YoY Change	-87.7%	-95.82%	-96.73%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.100M	$2.600M	$6.400M
YoY Change	-99.03%	-99.19%	-97.96%
Total Short-Term Liabilities	$423.7M	$443.3M	$481.0M
YoY Change	-40.35%	-34.39%	-23.53%
LONG-TERM LIABILITIES
Long-Term Debt	$2.243B	$2.240B	$2.193B
YoY Change	18.02%	17.96%	16.35%
Other Long-Term Liabilities	$355.0M	$364.1M	$389.1M
YoY Change	-18.69%	-17.09%	-6.07%
Total Long-Term Liabilities	$355.0M	$364.1M	$389.1M
YoY Change	-18.69%	-17.09%	-6.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$423.7M	$443.3M	$481.0M
Total Long-Term Liabilities	$355.0M	$364.1M	$389.1M
Total Liabilities	$3.198B	$3.228B	$3.232B
YoY Change	0.03%	1.98%	4.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.137B	-$2.989B	-$2.822B
YoY Change	29.59%	32.59%	35.89%
Common Stock	$6.257B	$6.207B	$6.087B
YoY Change	6.44%	6.77%	6.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.109B	$3.209B	$3.258B
YoY Change
Total Liabilities & Shareholders Equity	$6.307B	$6.437B	$6.491B
YoY Change	-5.23%	-4.27%	-3.62%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$148.8M	-$166.1M	-$180.9M
YoY Change	-10.89%	-6.13%	480.6%
Depreciation, Depletion And Amortization	$25.00M	$25.50M	$22.99M
YoY Change	12.11%	18.6%	12.12%
Cash From Operating Activities	-$40.93M	-$60.92M	-$173.8M
YoY Change	0.37%	-251.02%	124.99%
INVESTING ACTIVITIES
Capital Expenditures	-$44.64M	-$63.33M	$33.62M
YoY Change	14.84%	9.83%	160.24%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities	$109.6M	$84.99M	$7.000K
YoY Change	-1156.99%	-111.55%	-95.04%
Cash From Investing Activities	$65.00M	$21.66M	$45.56M
YoY Change	-232.01%	-102.73%	-114.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	235.0K	63.41M	$2.735M
YoY Change	190.12%	375.28%	-62.25%
NET CHANGE
Cash From Operating Activities	-40.93M	-60.92M	-$173.8M
Cash From Investing Activities	65.00M	21.66M	$45.56M
Cash From Financing Activities	235.0K	63.41M	$2.735M
Net Change In Cash	24.31M	24.16M	-$125.7M
YoY Change	-127.03%	-103.26%	-67.56%
FREE CASH FLOW
Cash From Operating Activities	-$40.93M	-$60.92M	-$173.8M
Capital Expenditures	-$44.64M	-$63.33M	$33.62M
Free Cash Flow	$3.711M	$2.410M	-$207.4M
YoY Change	-294.91%	-97.54%	130.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Shell Company EntityShellCompany	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001124140
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2022Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-35092
	dei	Entity Registrant Name EntityRegistrantName	EXACT SCIENCES CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	02-0478229
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5505 Endeavor Lane
	dei	Entity Address City Or Town EntityAddressCityOrTown	Madison
	dei	Entity Address State Or Province EntityAddressStateOrProvince	WI
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	53719
	dei	City Area Code CityAreaCode	608
	dei	Local Phone Number LocalPhoneNumber	535-8815
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
	dei	Trading Symbol TradingSymbol	EXAS
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	176959543	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	213421000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	315471000	usd
CY2022Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	514623000	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	715005000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	186542000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	216645000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	115172000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	104994000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	71875000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	74122000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1101633000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1426237000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	663653000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	580248000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	182494000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	174225000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	2345922000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	2335172000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2046773000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2094411000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	96680000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	74591000	usd
CY2022Q2	us-gaap	Assets Assets	6437155000	usd
CY2021Q4	us-gaap	Assets Assets	6684884000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	84167000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	67829000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	308219000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	398556000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	25813000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	19710000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	25132000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	30973000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	443331000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	517068000	usd
CY2022Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	2183145000	usd
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	2180232000	usd
CY2022Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	50000000	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	0	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	364107000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	417782000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	187226000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	182166000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	3227809000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3297248000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	176801434	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	176801434	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	173674067	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	173674067	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	1769000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1738000	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6204742000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6028861000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-8645000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1443000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2988520000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2641520000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3209346000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3387636000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6437155000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6684884000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	521640000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	434819000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1008211000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	836896000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	144600000	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	113968000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	279305000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	223961000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	106083000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	106235000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	208331000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	221802000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	215922000	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	194827000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	448103000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	380968000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	181672000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	167629000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	351442000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	435356000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	26356000	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	23824000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51010000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	47014000	usd
CY2022Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	6591000	usd
CY2021Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	6591000	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	681224000	usd
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	606483000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1344782000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1309101000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-159584000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-171664000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-336571000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-472205000	usd
CY2022Q2	exas	Investment Income Expense Nonoperating InvestmentIncomeExpenseNonoperating	-3719000	usd
CY2021Q2	exas	Investment Income Expense Nonoperating InvestmentIncomeExpenseNonoperating	3429000	usd
	exas	Investment Income Expense Nonoperating InvestmentIncomeExpenseNonoperating	-5206000	usd
	exas	Investment Income Expense Nonoperating InvestmentIncomeExpenseNonoperating	34617000	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4511000	usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4652000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-8989000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9268000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8230000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1223000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14195000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	25349000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-167814000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-172887000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-350766000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-446856000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1751000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4025000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3766000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-238780000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-166063000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-176912000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-347000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-208076000	usd
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.94
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.94
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.03
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.98
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.98
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.22
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	176364000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	176364000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	171494000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	171494000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	175396000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	175396000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	170469000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	170469000	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-166063000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-176912000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-347000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-208076000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1488000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-297000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-6455000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-629000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-510000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-747000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	0	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	0	usd
CY2022Q2	exas	Comprehensive Income Loss Before Tax ComprehensiveIncomeLossBeforeTax	-168061000	usd
CY2021Q2	exas	Comprehensive Income Loss Before Tax ComprehensiveIncomeLossBeforeTax	-177209000	usd
	exas	Comprehensive Income Loss Before Tax ComprehensiveIncomeLossBeforeTax	-354202000	usd
	exas	Comprehensive Income Loss Before Tax ComprehensiveIncomeLossBeforeTax	-208705000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	usd
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-170000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-168061000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-177209000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-354202000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-208535000	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3387636000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4282000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	52441000	usd
CY2022Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	7000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-180937000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-5204000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	3258211000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	743000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	29202000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	58932000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	14790000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	15529000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-166063000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1998000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3209346000	usd
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	2235552000	usd
CY2021Q1	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	344	shares
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	26000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8759000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	22934000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	158252000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1254798000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-31164000	usd
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-162000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	3648995000	usd
CY2021Q2	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	197	shares
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	14000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2858000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	56285000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	16120000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	12038000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-176912000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-297000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	3559101000	usd
	us-gaap	Profit Loss ProfitLoss	-347000000	usd
	us-gaap	Profit Loss ProfitLoss	-208076000	usd
	us-gaap	Depreciation Depreciation	48498000	usd
	us-gaap	Depreciation Depreciation	42007000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-166000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-639000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-4247000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	2486000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4940000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-244509000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	111373000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	133577000	usd
	exas	Post Combination Expense For Acceleration Of Unvested Equity PostCombinationExpenseForAccelerationOfUnvestedEquity	0	usd
	exas	Post Combination Expense For Acceleration Of Unvested Equity PostCombinationExpenseForAccelerationOfUnvestedEquity	80960000	usd
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	0	usd
	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	30500000	usd
	exas	Amortization Deferred Amortization Of Deferred Financing Costs Debt Discounts Premiums And Issuance Costs Other Liabilities AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities	3420000	usd
	exas	Amortization Deferred Amortization Of Deferred Financing Costs Debt Discounts Premiums And Issuance Costs Other Liabilities AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities	3282000	usd
	exas	Increase Decrease In Amortization Of Premium On Short Term Investments IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments	1493000	usd
	exas	Increase Decrease In Amortization Of Premium On Short Term Investments IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments	1616000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51010000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	47014000	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	6591000	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	usd
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	85337000	usd
	exas	Business Combination Contingent Consideration Gain Loss Change In Fair Value BusinessCombinationContingentConsiderationGainLossChangeInFairValue	51759000	usd
	exas	Business Combination Contingent Consideration Gain Loss Change In Fair Value BusinessCombinationContingentConsiderationGainLossChangeInFairValue	-9201000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	17281000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	11837000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-30632000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8995000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10178000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4267000	usd
	exas	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-10668000	usd
	exas	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-7095000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-79339000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	27138000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	5497000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	94000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-234670000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-36890000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	79110000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	915289000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	269310000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	325380000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	96949000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37504000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-685000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	415549000	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	0	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	58073000	usd
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	26667000	usd
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	10000000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	49000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	244000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	67220000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1111279000	usd
	us-gaap	Proceeds From Accounts Receivable Securitization ProceedsFromAccountsReceivableSecuritization	50000000	usd
	us-gaap	Proceeds From Accounts Receivable Securitization ProceedsFromAccountsReceivableSecuritization	0	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	5025000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	11617000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	15529000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	12038000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-4407000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-3068000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	66147000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20587000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-747000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-102050000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1127582000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315768000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1491594000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	213718000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	364012000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	34604000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	15139000	usd
	exas	Business Combination Contingent Consideration Arrangements Increase Due To Acquisition BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition	4600000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1008211000	usd
	exas	Business Combination Contingent Consideration Arrangements Increase Due To Acquisition BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition	350348000	usd
	us-gaap	Interest Paid Net InterestPaidNet	5133000	usd
	us-gaap	Interest Paid Net InterestPaidNet	5414000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	213421000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	363715000	usd
CY2022Q2	us-gaap	Restricted Cash RestrictedCash	297000	usd
CY2021Q2	us-gaap	Restricted Cash RestrictedCash	297000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	213718000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	364012000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those that affect the Company’s financial statements materially and involve difficult, subjective or complex judgments by management, and actual results could differ from those estimates. These estimates include revenue recognition, valuation of intangible assets and goodwill, and accounting for income taxes among others. The Company’s critical accounting policies and estimates are explained further in the notes to the condensed consolidated financial statements in this Quarterly Report and the 2021 Form 10-K.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread of the coronavirus (“COVID-19”) has affected many segments of the global economy, including the cancer screening and diagnostics industry. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of June 30, 2022 and through the date of the filing of this Quarterly Report on Form 10-Q. The accounting matters assessed included, but were not limited to, the Company’s allowance for doubtful accounts and credit losses, marketable and non-marketable investments, software, and the carrying value of the goodwill and other long-lived assets. The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company’s consolidated financial statements in future reporting periods.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic and related precautionary measures began to materially disrupt the Company's operations in March 2020 and may continue to disrupt the business for an unknown period of time. As a result, the pandemic had an impact on the Company’s revenues and operating results. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ultimate impact of COVID-19 depends on factors beyond the Company’s knowledge or control, including the duration and severity of the outbreak, as well as third-party actions taken to contain its spread and mitigate its public health effects. As a result, the Company is unable to estimate the extent to which COVID-19 will negatively impact its financial results or liquidity.</span></div>
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	836896000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation in the condensed consolidated financial statements and accompanying notes to the condensed consolidated financial statements.</span></div>
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28801000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28153000	shares
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	521640000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	434819000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1200000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1000000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	100000	usd
CY2021Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	10400000	usd
CY2021Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	10400000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	400000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	24400000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	24400000	usd
CY2022Q2	us-gaap	Cash Cash	157219000	usd
CY2021Q4	us-gaap	Cash Cash	247335000	usd
CY2022Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	56202000	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	68136000	usd
CY2022Q2	us-gaap	Restricted Cash RestrictedCash	297000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	297000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	213718000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315768000	usd
CY2022Q2	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1103000	usd
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	3336000	usd
CY2022Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	514623000	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	715005000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	728341000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	1030773000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	577643000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2000	usd
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	7923000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	569722000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	781271000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	17000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1483000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	779805000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	438885000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	433456000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	138758000	usd
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	136266000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	187200000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	499312000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	7923000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	499312000	usd
CY2022Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	7923000	usd
CY2022Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	57087000	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	51321000	usd
CY2022Q2	exas	Inventory Finished And Semi Finished Goods InventoryFinishedAndSemiFinishedGoods	58085000	usd
CY2021Q4	exas	Inventory Finished And Semi Finished Goods InventoryFinishedAndSemiFinishedGoods	53673000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	201900000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	115172000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	104994000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	923685000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	795064000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	260032000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	214816000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	663653000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	580248000	usd
CY2022Q2	us-gaap	Depreciation Depreciation	25500000	usd
CY2021Q2	us-gaap	Depreciation Depreciation	21500000	usd
	us-gaap	Depreciation Depreciation	48500000	usd
	us-gaap	Depreciation Depreciation	42000000	usd
CY2022Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	165400000	usd
CY2022Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2291571000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	244798000	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	311800000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1041571000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	244798000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	796773000	usd
CY2022Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1250000000	usd
CY2022Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1250000000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2046773000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1042808000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	198397000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	844411000	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1250000000	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1250000000	usd
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2292808000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	198397000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2094411000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-40000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	2345922000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	49288000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	98574000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	98240000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	97192000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	96132000	usd
CY2022Q2	exas	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	357347000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	796773000	usd
CY2022Q2	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	6600000	usd
CY2020Q4	us-gaap	Goodwill Goodwill	1237672000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	2335172000	usd
CY2022Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	359000000	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	359021000	usd
	exas	Business Combination Contingent Consideration Purchase Price BusinessCombinationContingentConsiderationPurchasePrice	4600000	usd
	exas	Business Combination Contingent Consideration Gain Loss Change In Fair Value BusinessCombinationContingentConsiderationGainLossChangeInFairValue	51759000	usd
	exas	Business Combination Contingent Consideration Additional Payment BusinessCombinationContingentConsiderationAdditionalPayment	77000	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	311785000	usd
CY2022Q2	exas	Financing Receivable Amount Elected To Collateralize FinancingReceivableAmountElectedToCollateralize	50000000	usd
	exas	Principal Amount Convertible Note PrincipalAmountConvertibleNote	1000	usd
	exas	Debt Instrument Repurchase Price Due To Change In Control As Percentage Of Principal Amount DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount	100
CY2022Q2	us-gaap	Share Price SharePrice	39.39
	exas	Coupon Interest Expense CouponInterestExpense	5133000	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1428000	usd
CY2021Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1428000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2840000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2840000	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	37000	usd
	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	230000	usd
CY2021Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	37000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	73000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	73000	usd
CY2022Q2	exas	Coupon Interest Expense CouponInterestExpense	2566000	usd
CY2021Q2	exas	Coupon Interest Expense CouponInterestExpense	2566000	usd
	exas	Coupon Interest Expense CouponInterestExpense	5133000	usd
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	4031000	usd
CY2021Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	4031000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	8046000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	8046000	usd
CY2022Q2	us-gaap	Interest Expense Other InterestExpenseOther	480000	usd
CY2021Q2	us-gaap	Interest Expense Other InterestExpenseOther	621000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	943000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	1222000	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4511000	usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4652000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-8989000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9268000	usd
	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	-7298000	usd
	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	-96000	usd
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-7202000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	19700000	usd
	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	-399000	usd
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-629000	usd
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-170000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	58900000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	56300000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	111400000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	219700000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5000000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11600000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2845000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2443000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	22158000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	54451000	usd
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y5M4D
	us-gaap	Operating Lease Payments OperatingLeasePayments	15899000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	12309000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	56000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	480000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	6033000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	2308000	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y3M29D
CY2022Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y7M20D
CY2021Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y3M10D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0611
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0632
CY2022Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0609
CY2021Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0554
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8100000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	182500000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	174200000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	213000000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	25800000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	182200000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9500000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	18200000	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	9700000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2600000	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	7100000	usd
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	18700000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	6200000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	12500000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10300000	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	10800000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8100000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	8600000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	521640000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	434819000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1008211000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	836896000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1800000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000000.0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3800000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-238800000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	27400000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	24400000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	21800000	usd

Files In Submission

Name	View Source	Status
0001124140-22-000061-index-headers.html	Edgar Link	pending
0001124140-22-000061-index.html	Edgar Link	pending
0001124140-22-000061.txt	Edgar Link	pending
0001124140-22-000061-xbrl.zip	Edgar Link	pending
exas-20220630.htm	Edgar Link	pending
exas-20220630.xsd	Edgar Link	pending
exas-20220630xexx311.htm	Edgar Link	pending
exas-20220630xexx312.htm	Edgar Link	pending
exas-20220630xexx321.htm	Edgar Link	pending
exas-20220630_cal.xml	Edgar Link	unprocessable
exas-20220630_def.xml	Edgar Link	unprocessable
exas-20220630_htm.xml	Edgar Link	completed
exas-20220630_lab.xml	Edgar Link	unprocessable
exas-20220630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXAS
EXACT SCIENCES CORP Stock $exas

2022 Q3 Form 10-Q Financial Statement

#000112414022000061 Filed on August 02, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS EXACT SCIENCES CORP Stock $exas

2022 Q3 Form 10-Q Financial Statement

#000112414022000061 Filed on August 02, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXAS
EXACT SCIENCES CORP Stock $exas